Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
Identifieur interne : 000176 ( Main/Curation ); précédent : 000175; suivant : 000177Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
Auteurs : Michael Samuel [Royaume-Uni] ; Maria Rodriguez-Oroz ; Angelo Antonini ; Jonathan M. Brotchie ; Kallol Ray Chaudhuri ; Richard G. Brown ; Wendy R. Galpern ; Melissa J. Nirenberg ; Michael S. Okun ; Anthony E. LangSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
English descriptors
- KwdEn :
- Animals, Antiparkinson Agents (therapeutic use), Deep Brain Stimulation (methods), Dopamine Agonists (therapeutic use), Humans, Impulse Control Disorders (complications), Impulse Control Disorders (therapy), Impulsive Behavior (drug effects), Impulsive Behavior (physiology), Parkinson Disease (complications), Parkinson Disease (therapy).
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists.
- complications : Impulse Control Disorders, Parkinson Disease.
- drug effects : Impulsive Behavior.
- methods : Deep Brain Stimulation.
- physiology : Impulsive Behavior.
- therapy : Impulse Control Disorders, Parkinson Disease.
- Animals, Humans.
Abstract
Impulse control disorders in Parkinson's disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies, including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, nonpharmacological treatments (such as cognitive behavioral therapy and deep brain stimulation), and other as yet experimental strategies.
DOI: 10.1002/mds.26099
PubMed: 25607799
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000285
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000285
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000176
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004224
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :004224
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :004224
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :000176
Links to Exploration step
pubmed:25607799Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.</title>
<author><name sortKey="Samuel, Michael" sort="Samuel, Michael" uniqKey="Samuel M" first="Michael" last="Samuel">Michael Samuel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's Health Partners, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's Health Partners, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Maria" sort="Rodriguez Oroz, Maria" uniqKey="Rodriguez Oroz M" first="Maria" last="Rodriguez-Oroz">Maria Rodriguez-Oroz</name>
</author>
<author><name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
</author>
<author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M" last="Brotchie">Jonathan M. Brotchie</name>
</author>
<author><name sortKey="Ray Chaudhuri, Kallol" sort="Ray Chaudhuri, Kallol" uniqKey="Ray Chaudhuri K" first="Kallol" last="Ray Chaudhuri">Kallol Ray Chaudhuri</name>
</author>
<author><name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G" last="Brown">Richard G. Brown</name>
</author>
<author><name sortKey="Galpern, Wendy R" sort="Galpern, Wendy R" uniqKey="Galpern W" first="Wendy R" last="Galpern">Wendy R. Galpern</name>
</author>
<author><name sortKey="Nirenberg, Melissa J" sort="Nirenberg, Melissa J" uniqKey="Nirenberg M" first="Melissa J" last="Nirenberg">Melissa J. Nirenberg</name>
</author>
<author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S" last="Okun">Michael S. Okun</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25607799</idno>
<idno type="pmid">25607799</idno>
<idno type="doi">10.1002/mds.26099</idno>
<idno type="wicri:Area/PubMed/Corpus">000285</idno>
<idno type="wicri:Area/PubMed/Curation">000285</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000176</idno>
<idno type="wicri:Area/Ncbi/Merge">004224</idno>
<idno type="wicri:Area/Ncbi/Curation">004224</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004224</idno>
<idno type="wicri:Area/Main/Merge">000176</idno>
<idno type="wicri:Area/Main/Curation">000176</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.</title>
<author><name sortKey="Samuel, Michael" sort="Samuel, Michael" uniqKey="Samuel M" first="Michael" last="Samuel">Michael Samuel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's Health Partners, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's Health Partners, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Maria" sort="Rodriguez Oroz, Maria" uniqKey="Rodriguez Oroz M" first="Maria" last="Rodriguez-Oroz">Maria Rodriguez-Oroz</name>
</author>
<author><name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
</author>
<author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M" last="Brotchie">Jonathan M. Brotchie</name>
</author>
<author><name sortKey="Ray Chaudhuri, Kallol" sort="Ray Chaudhuri, Kallol" uniqKey="Ray Chaudhuri K" first="Kallol" last="Ray Chaudhuri">Kallol Ray Chaudhuri</name>
</author>
<author><name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G" last="Brown">Richard G. Brown</name>
</author>
<author><name sortKey="Galpern, Wendy R" sort="Galpern, Wendy R" uniqKey="Galpern W" first="Wendy R" last="Galpern">Wendy R. Galpern</name>
</author>
<author><name sortKey="Nirenberg, Melissa J" sort="Nirenberg, Melissa J" uniqKey="Nirenberg M" first="Melissa J" last="Nirenberg">Melissa J. Nirenberg</name>
</author>
<author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S" last="Okun">Michael S. Okun</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Deep Brain Stimulation (methods)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Humans</term>
<term>Impulse Control Disorders (complications)</term>
<term>Impulse Control Disorders (therapy)</term>
<term>Impulsive Behavior (drug effects)</term>
<term>Impulsive Behavior (physiology)</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Impulse Control Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Impulsive Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Deep Brain Stimulation</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Impulsive Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Impulse Control Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Impulse control disorders in Parkinson's disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies, including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, nonpharmacological treatments (such as cognitive behavioral therapy and deep brain stimulation), and other as yet experimental strategies.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000176 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000176 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= pubmed:25607799 |texte= Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:25607799" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |